Chris Painter
Health Economist
Chris Painter’s research focuses on using health economics and health technology assessment methods to inform resource allocation policy decisions for a wide range of communicable and non-communicable diseases. This typically involves a comparison between the economic costs and health impacts of different health interventions to understand which intervention(s) are most cost-effective to use in practice.
A Health Economist at MORU MAEMOD’s Neglected Tropical Diseases Modeling (NTDM) Group since 2022, Chris’ current work focusses on: (ACORN) A Clinically Oriented antimicrobial Resistance Network; the ACT-South Asia (Azithromycin and Cefixime treatment of typhoid in South Asia) trial; and working with LOMWRU, MORU’s Lao PDR Unit, on the newly formed Unit for Health Evidence and Policy (UHEP) in Vientiane.
Chris’ ongoing research interests include antimicrobial resistance (AMR); COVID-19; Hepatitis C virus; and health economics and health technology assessment methods and institutionalising these methods in low- and middle-income countries (LMICs)
Holder of both an MSc and a BSc Economics from the University of Manchester, prior to MORU Chris worked as a health economist in the UK private sector and as an Overseas Development Institute Fellow (2019-2022) at the Health Intervention and Technology Assessment Program (HITAP) in Thailand’s Ministry of Public Health.
Recent publications
-
A systematic literature review of economic evaluation studies of interventions impacting antimicrobial resistance.
Journal article
Painter C. et al, (2023), Antimicrobial resistance and infection control, 12
-
Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic.
Journal article
Wang Y. et al, (2023), The European journal of health economics : HEPAC : health economics in prevention and care, 24, 735 - 748
-
How to model the impact of vaccines for policymaking when the characteristics are uncertain: A case study in Thailand prior to the vaccine rollout during the COVID-19 pandemic.
Journal article
Luangasanatip N. et al, (2023), Vaccine, 41, 4854 - 4860
-
A model-based study to estimate the health and economic impact of health technology assessment in Thailand.
Journal article
Kingkaew P. et al, (2022), International journal of technology assessment in health care, 38
-
A protocol for a systematic literature review of economic evaluation studies of interventions to address antimicrobial resistance.
Journal article
Ananthakrishnan A. et al, (2021), Systematic reviews, 10